Wezlana 45 mg

WEZLANA 45 MG is a subcutaneous solution containing ustekinumab, used for managing moderate to severe plaque psoriasis. This biologic medication helps reduce inflammation and improve skin condition.

WEZLANA 45 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults. It works by targeting specific proteins in the body to reduce inflammation and slow down the overproduction of skin cells. This medication is often considered when other treatments have not been effective or are not suitable.

Common effects of WEZLANA 45 MG may include redness, swelling, or itching at the injection site. Some individuals might experience headaches, nausea, or fatigue. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

WEZLANA 45 MG should be stored at room temperature and protected from light. It is important to follow proper injection techniques and dispose of used needles safely. Individuals with a history of allergic reactions to ustekinumab or any of its components should avoid using this medication.

WEZLANA 45 MG may interact with other medications, including biologics and immunosuppressants. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Alcohol and certain over-the-counter drugs may also affect the efficacy or safety of this medication.